A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis (ESCAPE-NEXT Trial)

Project: Research

Project Details

StatusActive
Effective start/end date6/04/215/04/26

Keywords

  • clinical trial
  • stroke
  • treatment efficacy
  • treatment safety